Effectiveness of systematic screening for the detection of atrial fibrillation

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  Moran, Patrick S ^a   Flattery, Martin J ^a   Teljeur, Conor ^a   Ryan, Mairin ^a   Smith, Susan M ^b  

^a HEALTH INFORMATION AND QUALITY AUTHORITY   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ATRIAL FIBRILLATION; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONSULTATION; COST BENEFIT ANALYSIS; ELECTROCARDIOGRAM; HEALTH CARE COST; HUMAN; MEDICAL PRACTICE; OPPORTUNISTIC SCREENING; OUTCOME ASSESSMENT; PALPATION; PATIENT IDENTIFICATION; PATIENT SAFETY; PRIORITY JOURNAL; PROGRAM ACCEPTABILITY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING; SEX DIFFERENCE; SYSTEMATIC REVIEW; SYSTEMATIC SCREENING; AGED; ASYMPTOMATIC DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; MALE; MASS SCREENING; METHODOLOGY;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; PALPATION; PULSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84881309831     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009586.pub2     Document Type: Review

References (79)

1. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al.Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335(7616):383.
2. Hobbs FDR, Fitzmaurice DA, Jowett S, Mant J, Murray E, Bryan S, et al.A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technology Assessment 2005;9:40.
3. Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, et al.Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007;335(7616):380.
4. Swancutt D, Hobbs R, Fitzmaurice D, Mant J, Murray E, Jowett S, et al.A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC cardiovascular disorders 2004;4:12.
5. Freedman B. Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke (SEARCH-AF). Australian New Zealand Clinical Trials Registry 2012;Trial Identifier: ACTRN12612000406808.
6. Baxter J, Crabtree L, Hildreth A, Gray C, O'Connell J. Atrial fibrillation. Lancet 1998;352(9143):1858.
7. Claes N, Van Laethem C, Goethals M, Goethals P, Mairesse G, Schwagten B, et al.Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium. Acta Cardiologica 2012;67(3):273-8.
8. De Ruijter W, Assendelft WJ, Macfarlane PW, Westendorp RG, Gussekloo J. The additional value of routine electrocardiograms in cardiovascular risk management of older people. Scandinavian Journal of Primary Health Care 2008;26(3):147-53.
9. Ho SF, O'Mahony MS, Steward JA, Burr ML, Buchalter M. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?. Age and Ageing 2004;33(5):488-92.
10. Hoefman E, van Weert HC, Reitsma JB, Koster RW, Bindels PJ. Diagnostic yield of patient-activated loop recorders for detecting heart rhythm abnormalities in general practice: a randomised clinical trial. Family Practice 2005;22(5):478-84.
11. Johnson BJ, Urrutia V. Stroke risk factor screening in an inner city public market - A description of the population - A better target for screening/education efforts. Stroke 2010;41:e200-53.
12. Maeda K, Shimbo T, Fukui T. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. Journal of Medical Screening 2004;11(2):97-102.
13. Marek J, Bufalino V, Davis J, Marek K, Gami A, Stephan W, et al.Feasibility and findings of large-scale electrocardiographic screening in young adults: data from 32, 561 subjects. Heart Rhythm 2011;8(10):1555-9.
14. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. The British Journal of General Practice 2002;52(478):373-4, 377-80.
15. Munschauer FE, Hens MM, Priore RL, Stolarski E, Buffamonte S, Carlin A, et al.Screening for atrial fibrillation in the community: a multicenter validation trial. Journal of Stroke and Cerebrovascular Diseases 1999;8(2):99-103.
16. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. The British Journal of General Practice 2000;50(458):727-9.
17. Sudlow M, Rodgers H, Kenny RA, Thomson R. Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ 1998;317(7154):327-8.
18. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart 1998;79(1):50-5.
19. Wright J, Bibby J, Eastham J, Harrison S, McGeorge M, Patterson C, et al.Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Quality & Safety in Health Care 2007;16(1):51-9.
20. NCT01291953. Effectiveness of Early Detection of Atrial Fibrillation (FAMDAP). http://www.clinicaltrials.gov/ct2/show/NCT01291953 (accessed 24/01/2013).
21. NCT01593553. Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden. http://www.clinicaltrials.gov/ct2/show/NCT01593553?term=NCT01593553&rank=1 (accessed 24/01/2013).
22. Barratt A, Mannes P, Irwig L, Trevena L, Craig J, Rychetnik L. Cancer screening. Journal of Epidemiology and Community Health 2002;56(12):899-902.
23. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271(11):840-4.
24. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98(10):946-52.
25. Bilato C, Corti MC, Baggio G, Rampazzo D, Cutolo A, Iliceto S, Crepaldi G. Prevalence, functional impact and mortality of atrial fibrillation in an older Italian population (from the PRO.V.A Study). American Journal of Cardiology 2009;104:1092-7.
26. Caldwell JC, Borbas Z, Donald A, Clifford A, Bolger L, Black A, et al.Simplified electrocardiogram sampling maintains high diagnostic capability for atrial fibrillation: implications for opportunistic atrial fibrillation screening in primary care. Europace 2012;14(2):191-6.
27. CDC. Utilization of Ambulatory Medical Care by Women: United States, 1997-98. Series Report 13, No. 149. 51 pp. http://www.cdc.gov/nchs/data/series/sr_13/sr13_149.pdf 2001.
28. Cooke G, Doust J, Sanders S. Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. Journal of Family Practice 2006;55(2):130-4.
29. Cullinane M, Wainwright R, Brown A, Monaghan M, Markus HS. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke 1998;29(9):1810-5.
30. Cochrane Effective Practice and Organisation of Care Group. EPOC resources for review authors. http://epoc.cochrane.org/epoc-resources-review-authors 2011.
31. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal 2010;31(19):2369-429.
32. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R. Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of Internal Medicine 1995;155(5):469-73.
33. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al.Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335(7616):383.
34. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation [published erratum appears in Lancet 1987;1:878]. Lancet 1987;1:526-9.
35. Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials. Lippincott Williams & Wilkins; Fourth edition, 2005.
36. Frazier TG, Cummings PD. Motivational factors for participation in breast cancer screening. Journal of Cancer Education 1990;5(1):51-4.
37. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14:666-72.
38. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. European Heart Journal 2010;31:967-75.
39. Friedemann-Sánchez G, Griffin JM, Partin MR. Gender differences in colorectal cancer screening barriers and information needs. Health Expectations 2007;10(2):148-60.
40. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology 1994;74:236-41.
41. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of CardiologyCommittee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Journal of the American College of Cardiology 2006;48:149-246.
42. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al.Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
43. Goroll AH, May LA, Mulley AG. Primary Care Medicine. 3rd Edition. Philadelphia: Lippincott, 1995:13-6.
44. Gowd BM, Thompson PD. Effect of female sex on cardiac arrhythmias. Cardiology in Review 2012;20(6):297-303.
45. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. American Journal of Cardiology 1992;69(19):1570-3.
46. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: Reflections from 4 current and former members of the U.S. Preventive Services Task Force. Epidemiologic Reviews 2011;33:20-35.
47. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation?. The Journal of the Royal College of Physicians of Edinburgh 2012;42 Suppl 18:5-22.
48. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine 2007;146(12):857-67.
49. Heeringa J, van de Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHCh, et al.Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal 2006;27:949-53.
50. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011; Vol. Available from www.cochrane-handbook.org.
51. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, et al.Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Journal of the American College of Cardiology 2007;50(22):2156-61.
52. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technology Assessment 2000;4(14):1-133.
53. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. American Heart Journal 1983;106:389-96.
54. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. American Journal of Medicine 1995;98:476-84.
55. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, et al.International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 2003;5:119-22.
57. Lin HJ, Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke 1995;26(9):1527-30.
58. Lin HJ, Wolf PA, Kelly Hayes M, et al.Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760-4.
59. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: A systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 2012;142(6):1489-98.
60. Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, et al.Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007;335(7616):380.
61. McGregor P, Nolan A, Nolan B, O'Neill, C. A comparison of GP visiting in Northern Ireland and the Republic of Ireland. ESRI Research Programme on Health Services, Health Inequalities and Health and Social Gain 2006;Working paper No. 22.
62. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians 2006.
63. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. American Journal of Medicine 2010;123(7):638-45.
64. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997 Feb;28(2):316-21.
65. Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P. Predicting the impact of the screening programme for colorectal cancer in the UK. Journal of Medical Screening 2008;15(4):163-74.
66. Peate I. Men's attitudes towards health and the implications for nursing care. British Journal of Nursing 2004;13(9):540-5.
67. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al.Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96(7):2455-61.
68. Savelieva I, Camm AC. Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life and management. Journal of Interventional Cardiac Electrophysiology 2000;4:369-82.
69. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. European Heart Journal 2001;22(8):693-701.
70. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine 2001;113(5):359-64.
71. Swancutt D, Hobbs R, Fitzmaurice D, Mant J, Murray E, Jowett S, et al.A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC Cardiovascular Disorders 2004;4:12.
72. Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. Journal of Medical Screening 2005;12(1):20-7.
73. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999:implications for primary prevention. Circulation 2003;108:711-6.
74. Weller DP, Campbell C. Uptake in cancer screening programmes: a priority in cancer control. British Journal of Cancer 2009;101 Suppl 2:S55-9.
75. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO, 1968.
76. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983;14(5):664-7.
77. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Archives of Internal Medicine 1987;147(9):1561-4.
78. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8.
79. Wyse DG, Waldo AL. DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al.A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine 2002;347(23):1825-33.